Amlodipine Besylate
Product Images NDC 53002-3249
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 53002-3249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Kaplan-meier Analysis Of Composite Clinical Outcomes For Amlodipine Versus Placebo Kaplan-meier Analysis Of Composite Clinical Outcomes For Amlodipine Versus Placebo Figure-02 (29d19981 1b28 4824 835b 729881d05ef3 02)
Figure-03 (29d19981 1b28 4824 835b 729881d05ef3 03)
This appears to be a table of results from a study evaluating the effectiveness of Amlodipine compared to a placebo in patients with baseline Sitting SBP (Systolic Blood Pressure). The table lists the number of patients in the study based on different criteria such as age, gender, baseline sitting SBP, baseline vessel disease, baseline vessels with stenosis, and PCl-stent strata. There are also hazard ratios listed at different intervals.*
Company Logo (29d19981 1b28 4824 835b 729881d05ef3 05)
Label Image (Lbl530023249)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.